← Back to Alivus Life Sciences Limited Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ALIVUSPharmaceuticals

Alivus Life Sciences Limited — Financial Ratios & Key Metrics

₹972.70

-0.40%

P/E Ratio20.98xIndustry: 31.77x

ROE18.69%Return on equity

ROCE24.92%Return on capital

Debt/Equity0.02Low debt

💎

Valuation & Profitability

P/E Ratio

20.98x

Industry Average P/E

31.77x

Dividend Yield

0.55%

Market Cap

₹11.13K (Cr)

Sales Growth 5Y

9.20%

Profit Growth 5Y

8.92%

EPS Growth 5Y

-52.37%

OPM 5Y Avg

29.62%

📉

Price Returns

1 Month

+0.02%

3 Months

-3.23%

6 Months

-11.62%

1 Year

-16.56%

52W Low

₹819

Current

₹973

52W High

₹1225

38% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹919

▲ Price above SMA 50 — Bullish

SMA 200

₹942

▲ Long-term uptrend

Volume Signal

221% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Alivus Life Sciences Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.